(Q38813097)

6 September 2017

1 reference

title

How we manage patients with hereditary haemochromatosis (English)

1 reference

6 September 2017

author name string

Eva Rombout-Sestrienkova

series ordinal

1

1 reference

6 September 2017

Marian G J van Kraaij

series ordinal

2

1 reference

6 September 2017

Ger H Koek

series ordinal

3

1 reference

6 September 2017

language of work or name

English

0 references

publication date

10 October 2016

1 reference

British Journal of Haematology

6 September 2017

published in

1 reference

6 September 2017

volume

175

1 reference

6 September 2017

issue

5

1 reference

6 September 2017

page(s)

759-770

1 reference

Factors affecting the rate of iron mobilization during venesection therapy for genetic hemochromatosis.

6 September 2017

cites work

1 reference

How I treat hemochromatosis.

21 January 2018

1 reference

Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.

21 January 2018

1 reference

Iron-overload-related disease in HFE hereditary hemochromatosis

21 January 2018

1 reference

HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis

21 January 2018

1 reference

Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases

21 January 2018

1 reference

Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.

21 January 2018

1 reference

Hemochromatosis and iron overload: from bench to clinic.

21 January 2018

1 reference

Silybin, a new iron-chelating agent.

21 January 2018

1 reference

Optimizing the diagnosis and the treatment of iron overload diseases

21 January 2018

1 reference

Contribution of different HFE genotypes to iron overload disease: a pooled analysis

21 January 2018

1 reference

Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study.

21 January 2018

1 reference

Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection

21 January 2018

1 reference

Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin

21 January 2018

1 reference

EASL clinical practice guidelines for HFE hemochromatosis

21 January 2018

1 reference

The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis

21 January 2018

1 reference

Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases.

21 January 2018

1 reference

Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis

21 January 2018

1 reference

Manipulation of the hepcidin pathway for therapeutic purposes

21 January 2018

1 reference

Non-invasive assessment of hepatic iron stores by MRI.

21 January 2018

1 reference

Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation

21 January 2018

1 reference

A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis

21 January 2018

1 reference

The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis.

21 January 2018

1 reference

Hereditary hemochromatosis: update for 2003.

21 January 2018

1 reference

Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis

21 January 2018

1 reference

The iron-chelating potential of silybin in patients with hereditary haemochromatosis

21 January 2018

1 reference

Hereditary haemochromatosis

21 January 2018

1 reference

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

21 January 2018

1 reference

Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis

21 January 2018

1 reference

Diagnosis and treatment of hereditary hemochromatosis: an update

21 January 2018

1 reference

Anticoagulation techniques in apheresis: from heparin to citrate and beyond

21 January 2018

1 reference

Non-invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis.

21 January 2018

1 reference

The iron reabsorption index: a new phenotypic and pathophysiological descriptor in HFE hemochromatosis

21 January 2018

1 reference

Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance

21 January 2018

1 reference

Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients.

21 January 2018

1 reference

Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)

21 January 2018

1 reference

Hepcidin, a urinary antimicrobial peptide synthesized in the liver

21 January 2018

1 reference

Worldwide policies on haemochromatosis and blood donation: a survey among blood services.

21 January 2018

1 reference

A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis

21 January 2018

1 reference

Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment

21 January 2018

1 reference

A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload

21 January 2018

1 reference

Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis

21 January 2018

1 reference

EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).

21 January 2018

1 reference

Steatosis is a cofactor in liver injury in hemochromatosis

21 January 2018

1 reference

21 January 2018

1 reference

Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis - A pilot study

21 January 2018

1 reference

Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial

21 January 2018

1 reference

End-stage cardiomyopathy because of hereditary hemochromatosis successfully treated with erythrocytapheresis in combination with left ventricular assist device support.

21 January 2018

1 reference

Course of iron parameters in HFE-hemochromatosis patients during initial treatment with erythrocytapheresis compared to phlebotomy.

21 January 2018

1 reference

Erythrocytapheresis versus phlebotomy in the maintenance treatment of HFE hemochromatosis patients: results from a randomized crossover trial.

21 January 2018

1 reference

Accuracy of magnetic resonance imaging in diagnosis of liver iron overload: a systematic review and meta-analysis

21 January 2018

1 reference

In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations

21 January 2018

1 reference

Cardiac transplantation in a patient with hereditary hemochromatosis: role of adjunctive phlebotomy and erythropoietin

21 January 2018

1 reference

Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.

21 January 2018

1 reference

Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation

21 January 2018

1 reference

Pattern of care of blood donors with early-uncomplicated hereditary haemochromatosis in a Swiss blood donation centre.

21 January 2018

1 reference

Reversal of cardiac complications by deferiprone and deferoxamine combination therapy in a patient affected by a severe type of juvenile hemochromatosis (JH)

21 January 2018

1 reference

A survey of phlebotomy among persons with hemochromatosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.14376

1 reference

6 September 2017

1 reference